Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions

摘要

Objectives: To investigate how the use of pharmacologic concomitant medications (CMs) is planned and reported in rheumatology randomized controlled trials (RCTs).